abcabcabc Dosimetry and Imaging | About Us
oelimaging

Board

D+I has a strong and experienced board and management team, introduced below.

Hans Roser AM – Chairman – AM, MPA, FAIM
Hans Roser was appointed Chairman of D+I in May 2011. Over the past 20 years Hans has worked for Kinhill Pty Ltd, one of Australia’s largest engineering consulting firms, for Thales Australia Ltd, and was a director of Eurocopter International. He has also chaired several Industry Associations and served on the board of several SMEs.

Stephen Hardy – Director – BSc, B. Eng, MBA
Stephen Hardy is an Executive Director of Hindmarsh and manages Australian Capital Ventures Limited (ACVL). Stephen has 30 years of experience in project management, development and construction in Australia, USA and Vietnam. Since 2000, Stephen has been the Chief Executive of ACVL, which manages a joint venture between Hindmarsh and the ACT Government in supporting and mentoring promising high technology companies from the ACT region.

Peter Janssen – Director – B.Ec, LLB (Syd), MBA (IMD), FAICD
Peter was appointed to the Board of D+I May 2011. He has spent most of his career building Utilux, an Australian based manufacturer of electrical and electronic components, and has extensive board experience with private, government and start up organisations.

Management

Ross Harricks – CEO – B.Eng, MBA (INSEAD)

Ross been involved with the development and international marketing of medical devices for many years, working in the UK, US and Australia. Ross has held numerous board positions with medical device companies and has been a co-founder of several successful medical companies. He has taken a start-ups from founding to listing, and has served on a number of private company and public company boards.

Professor Hans Riesen – Inventor, consultant – PhD (University of Berne)
Hans Riesen is a graduate of the University of Berne, Switzerland. He obtained his PhD (Dr. phil.-nat.) in 1987 for research with Prof. H.U. Güdel on the optical spectroscopy of exchange coupled binuclear chromium (III) complexes. In 1987 he joined the group of Prof. E. Krausz at the Research School of Chemistry (RSC) of the Australian National University (ANU) as a post-doctoral fellow (PDF).

In both 1986 and in 1989 he received awards by the Swiss National Science Foundation. In 1992 he was awarded a 5-year ARC Research Fellowship at Australian National University. In 1998 he joined UNSW as a lecturer and was promoted to Senior Lecturer and then Associate Professor in 2004.

Hans Riesen has pioneered the application of advanced laser spectroscopies to inorganic complexes. In recent years he also pioneered the application of inexpensive diode lasers in this field.
He is particularly interested in light-induced changes in the solid state (spectral hole-burning etc) which have a potential in applications such as ultra-high density (>100,000 Gigabyte/cm3) optical storage. He is the author of more than 80 research articles, which include two book chapters and several reviews.

Company Background

Dosimetry & Imaging (D+I) is a private company formed in 2007 to commercialise a breakthrough invention by Professor Hans Riesen at the University of NSW, Canberra, Australia).

The three major shareholders of D+I are ANU Connect Ventures, Australian Capital Ventures and New South Innovations, the commercialisation company of the University of NSW).

D&I is based in Canberra and in Sydney, Australia.

Contact Us

Ross Harricks, CEO
Dosimetry & Imaging, Sydney Australia

  • by Phone: +61 438 767 742

  • by E-mail: ross.harricks@gmail.com

  • by Skype: ross.harricks